Literature DB >> 3301300

Calcium antagonists in cerebral/peripheral vascular disorders. Current status.

K J Tietze, M L Schwartz, P H Vlasses.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3301300     DOI: 10.2165/00003495-198733060-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  44 in total

1.  Vasospastic diseases: a review.

Authors:  J D Coffman; W T Davies
Journal:  Prog Cardiovasc Dis       Date:  1975 Sep-Oct       Impact factor: 8.194

Review 2.  Raynaud syndrome.

Authors:  R J Blunt; J M Porter
Journal:  Semin Arthritis Rheum       Date:  1981-05       Impact factor: 5.532

3.  Nimodipine, a new calcium antagonist, in the prophylactic treatment of migraine.

Authors:  H J Gelmers
Journal:  Headache       Date:  1983-05       Impact factor: 5.887

4.  The effects of nifedipine, a calcium antagonist, on platelet function.

Authors:  J Dale; K H Landmark; E Myhre
Journal:  Am Heart J       Date:  1983-01       Impact factor: 4.749

5.  A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine.

Authors:  P Louis
Journal:  Headache       Date:  1981-11       Impact factor: 5.887

6.  Flunarizine v. placebo in childhood migraine. A double-blind study.

Authors:  F Sorge; E Marano
Journal:  Cephalalgia       Date:  1985-05       Impact factor: 6.292

7.  Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.

Authors:  C D Smith; R J McKendry
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

Review 8.  Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.

Authors:  E M Antman; P H Stone; J E Muller; E Braunwald
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

9.  Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

Authors:  G S Allen; H S Ahn; T J Preziosi; R Battye; S C Boone; S C Boone; S N Chou; D L Kelly; B K Weir; R A Crabbe; P J Lavik; S B Rosenbloom; F C Dorsey; C R Ingram; D E Mellits; L A Bertsch; D P Boisvert; M B Hundley; R K Johnson; J A Strom; C R Transou
Journal:  N Engl J Med       Date:  1983-03-17       Impact factor: 91.245

10.  Neurological recovery after cardiac arrest: clinical feasibility trial of calcium blockers.

Authors:  A C Schwartz
Journal:  Am J Emerg Med       Date:  1985-01       Impact factor: 2.469

View more
  2 in total

Review 1.  Thrombolytic treatment and new calcium antagonists.

Authors:  J Feely; T Pringle; D Maclean
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-05

Review 2.  Management of Raynaud's phenomenon. Focus on newer treatments.

Authors:  S Roath
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.